ArticlePancreas2026
High Rate of Exocrine Pancreatic Dysfunction in Pediatric Patients with Diabetes Mellitus.
Article in Pancreas, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveThis study aimed to describe the frequency of exocrine pancreatic disease in youth with diabetes.
methodsWe conducted a retrospective chart review on data that was obtained from a single-center prospectively collected database of patients with diabetes. Patients were categorized as having type 1 diabetes, type 2 diabetes, or "Other" diabetes if they had cystic fibrosis-related diabetes, maturity-onset diabetes of the young, or drug/chemical-induced diabetes. All patients' charts were reviewed for exocrine pancreas disease, inclusive of pancreatitis or exocrine pancreatic insufficiency.
resultsNine hundred eighty-eight patients with a diabetes diagnosis were included. Thirty-five out of 988 (3.5%) were diagnosed with pancreatic exocrine disease. Diabetes patients with exocrine disease compared with the ones without were significantly older (13.1 y, IQR 9.8-15.3 vs. 11.7 y, P = 0.04). Those with exocrine disease were more likely to have "Other" diabetes ( P <0.0001). The exocrine group had a lower median hemoglobin A1c at diabetes diagnosis (7%, IQR 5.8%-9.2% vs. 11.3%, 8.9%-13.8%; P <0.0001). Out of the 988 patients, 18 patients had pancreatitis diagnosed, which was 2% of the overall cohort. Nine of the 18 patients were found to have developed pancreatitis after diabetes diagnosis, or 1% of the entire diabetes cohort (9/988).
conclusionsThe co-existence of exocrine and endocrine pancreatic disease occurred in 3.5% of diabetes patients. The risk of pancreatitis occurring after diabetes was 1%, a rate 100 times higher than the general pediatric population (0.01%). Future studies are needed to determine the specific mechanisms involved in the connection between endocrine and exocrine pancreatic disease in children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.